Nuveen, LLC United Therapeutics Corp Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Nuveen, LLC holds 270,975 shares of UTHR stock, worth $84.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
270,975Holding current value
$84.2 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
729Shares Held
41.8MCall Options Held
123KPut Options Held
100K-
Black Rock Inc. New York, NY5.47MShares$1.7 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.39 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$858 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$684 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$649 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.1B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...